Cargando…
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
SIMPLE SUMMARY: Cholangiocarcinoma (CCA) is an architecturally complex and highly heterogeneous tumour and is difficult to diagnose at early stages due to its late onset and asymptomatic nature. Recent studies have focused on the Fibroblast Growth Factor Receptors (FGFRs), a sub-family of Tyrosine K...
Autores principales: | Balasubramanian, Brinda, Yacqub-Usman, Kiren, Venkatraman, Simran, Myint, Kyaw Zwar, Juengsamarn, Jitlada, Sarkhampee, Poowanai, Lertsawatvicha, Nithi, Sripa, Jittiyawadee, Kuakpaetoon, Thiti, Suriyonplengsaeng, Chinnawut, Wongprasert, Kanokpan, Grabowska, Anna M., Bates, David O., Janvilisri, Tavan, Tohtong, Rutaiwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177182/ https://www.ncbi.nlm.nih.gov/pubmed/37173994 http://dx.doi.org/10.3390/cancers15092528 |
Ejemplares similares
-
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
por: Boonsri, Boonyakorn, et al.
Publicado: (2021) -
Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling
por: Likhitrattanapisal, Somsak, et al.
Publicado: (2020) -
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2021) -
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
por: Balasubramanian, Brinda, et al.
Publicado: (2021) -
Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study
por: Chansitthichok, Satsawat, et al.
Publicado: (2020)